1. Home
  2. PRPH vs BREA Comparison

PRPH vs BREA Comparison

Compare PRPH & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPH
  • BREA
  • Stock Information
  • Founded
  • PRPH 1989
  • BREA 2022
  • Country
  • PRPH United States
  • BREA Ireland
  • Employees
  • PRPH N/A
  • BREA N/A
  • Industry
  • PRPH Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • PRPH Health Care
  • BREA Consumer Discretionary
  • Exchange
  • PRPH Nasdaq
  • BREA Nasdaq
  • Market Cap
  • PRPH 10.7M
  • BREA 8.7M
  • IPO Year
  • PRPH 1997
  • BREA 2023
  • Fundamental
  • Price
  • PRPH $0.39
  • BREA $0.69
  • Analyst Decision
  • PRPH
  • BREA
  • Analyst Count
  • PRPH 0
  • BREA 0
  • Target Price
  • PRPH N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • PRPH 1.7M
  • BREA 260.2K
  • Earning Date
  • PRPH 03-31-2025
  • BREA 01-03-2025
  • Dividend Yield
  • PRPH N/A
  • BREA N/A
  • EPS Growth
  • PRPH N/A
  • BREA N/A
  • EPS
  • PRPH N/A
  • BREA N/A
  • Revenue
  • PRPH $6,770,000.00
  • BREA $2,872,101.00
  • Revenue This Year
  • PRPH N/A
  • BREA N/A
  • Revenue Next Year
  • PRPH $64.06
  • BREA N/A
  • P/E Ratio
  • PRPH N/A
  • BREA N/A
  • Revenue Growth
  • PRPH N/A
  • BREA 2338.69
  • 52 Week Low
  • PRPH $0.22
  • BREA $0.50
  • 52 Week High
  • PRPH $7.48
  • BREA $1.95
  • Technical
  • Relative Strength Index (RSI)
  • PRPH 45.88
  • BREA 51.42
  • Support Level
  • PRPH $0.35
  • BREA $0.65
  • Resistance Level
  • PRPH $0.60
  • BREA $0.76
  • Average True Range (ATR)
  • PRPH 0.08
  • BREA 0.06
  • MACD
  • PRPH 0.00
  • BREA 0.00
  • Stochastic Oscillator
  • PRPH 27.59
  • BREA 53.28

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: